Literature DB >> 15292801

Does pain predict outcome in hips with osteonecrosis?

Carlos J Belmar1, Marvin E Steinberg, Karen M Hartman-Sloan.   

Abstract

It generally is accepted that without specific treatment 70-80% of hips with clinically diagnosed osteonecrosis will progress to collapse. However, there are conflicting reports regarding the relationship between pain and outcome before femoral head collapse. Some surgeons are reluctant to operate on patients with asymptomatic or minimally symptomatic hips, assuming that these patients have a better prognosis than patients with pain. This study reviewed the outcome of 328 hips in 235 patients with nontraumatic osteonecrosis, all treated with core decompression and grafting. The preoperative stage, the extent of necrosis, and the Harris pain scores were correlated with the clinical and radiographic outcomes. Mean followup was 46 months. Patients with hips treated surgically did better as a group than patients with hips treated without surgery. A direct correlation was found between outcome and the stage and size of the necrotic lesion. Hips that had femoral head collapse were more painful than hips that did not have collapse and had a poorer outcome. Before collapse, outcome was correlated with the size of the necrotic lesion but there was no correlation with the preoperative pain level. These findings, although limited to patients with hips which had core decompression and grafting, support the observations of investigators who reported that most asymptomatic hips with osteonecrosis would progress without specific treatment. They also may apply to hips which have other forms of prophylactic treatment. Although several factors must be considered in determining the optimum treatment of hips with early stages of osteonecrosis, prophylactic treatment should not be withheld specifically because of the absence or paucity of pain.

Entities:  

Mesh:

Year:  2004        PMID: 15292801     DOI: 10.1097/00003086-200408000-00021

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  6 in total

1.  Efficacy of tantalum rod insertion for preventing femoral head collapse in osteonecrosis in a paediatric population: a pilot study.

Authors:  Muqtasid Hussaini; Jitendra Balakumar; David Slattery
Journal:  J Hip Preserv Surg       Date:  2021-09-25

2.  The natural history of asymptomatic osteonecrosis of the femoral head.

Authors:  Joon Soon Kang; Kyoung Ho Moon; Dae Gyu Kwon; Byung Ki Shin; Min Su Woo
Journal:  Int Orthop       Date:  2013-01-23       Impact factor: 3.075

3.  The Efficacy of Bisphosphonates with Core Decompression and Mesenchymal Stem Cells Compared with Bisphosphonates Alone in the Treatment of Osteonecrosis of the Hip: a Retrospective Study.

Authors:  Arianna L Gianakos; Joaquin Moya-Angeler; Shivi Duggal; Lester Zambrana; Kara G Fields; Douglas N Mintz; Charles N Cornell; Joseph M Lane
Journal:  HSS J       Date:  2016-03-17

4.  Culture-Expanded Autologous Adipose-Derived Mesenchymal Stem Cell Treatment for Osteonecrosis of the Femoral Head.

Authors:  Pil Whan Yoon; Jong Yeal Kang; Chul-Ho Kim; Soong Joon Lee; Jeong Joon Yoo; Hee Joong Kim; Sung Keun Kang; Ju Hyeon Min; Kang Sup Yoon
Journal:  Clin Orthop Surg       Date:  2020-12-21

5.  The Value of the Frog Lateral View Radiograph for Detecting Collapse of Femur Head Necrosis: A Retrospective Study of 1001 Cases.

Authors:  Fan Yang; Xiaoqiang Deng; Pengfei Xin; Zhinan Hong; Fengxiang Pang; Wei He; Qiushi Wei; Ziqi Li
Journal:  Front Med (Lausanne)       Date:  2022-03-29

6.  Rationale for prostaglandin I2 in bone marrow oedema--from theory to application.

Authors:  Marcus Jäger; Frank Peter Tillmann; Thomas S Thornhill; Marcus Mahmoudi; Dirk Blondin; Gerd Rüdiger Hetzel; Christoph Zilkens; Rüdiger Krauspe
Journal:  Arthritis Res Ther       Date:  2008-10-03       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.